Thursday, May 2, 2019
Zymeworks expanding its leadership team
Zymeworks has just announced an expansion of their leadership team. They are bringing in Mark Hollywood from BMS to head the Technical and Manufacturing operations. Also Neil Josephson is coming over from SeaGen to head the clinical research. Additionally, Bruce Hart is coming from SeaGen as well to head the Regulatory Affairs group. And lastly, David Poon in being promoted internally to head up Business Development and Alliance Management.
What do all of these things have in common? Zymeworks is being proactive about their future development and building out a strong leadership structure to enable successful growth into pipeline commercialization. Clearly they have confidence that the future it bright. It will be interesting to see how things materialize over time.
Is this enough to get you excited? Or does it start to sound like a biotech company is building in layers of bureaucracy which will make advancement more difficult?